The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521
Publication
, Conference
Hall, WA; Karrison, TG; Rosenthal, SA; Amin, M; Gomella, LG; Purdy, JA; Sartor, O; Michalski, JM; Garzotto, M; Bergom, C; Jani, A; Lawton, CAF ...
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2018
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2018
Volume
102
Issue
3
Start / End Page
S13 / S14
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hall, W. A., Karrison, T. G., Rosenthal, S. A., Amin, M., Gomella, L. G., Purdy, J. A., … Feng, F. Y. (2018). The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521. In International Journal of Radiation Oncology*Biology*Physics (Vol. 102, pp. S13–S14). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2018.06.125
Hall, W. A., T. G. Karrison, S. A. Rosenthal, M. Amin, L. G. Gomella, J. A. Purdy, O. Sartor, et al. “The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521.” In International Journal of Radiation Oncology*Biology*Physics, 102:S13–14. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.06.125.
Hall WA, Karrison TG, Rosenthal SA, Amin M, Gomella LG, Purdy JA, et al. The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018. p. S13–4.
Hall, W. A., et al. “The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521.” International Journal of Radiation Oncology*Biology*Physics, vol. 102, no. 3, Elsevier BV, 2018, pp. S13–14. Crossref, doi:10.1016/j.ijrobp.2018.06.125.
Hall WA, Karrison TG, Rosenthal SA, Amin M, Gomella LG, Purdy JA, Sartor O, Michalski JM, Garzotto M, Bergom C, Jani A, Lawton CAF, Simko J, Moore J, Gore EM, Lee WR, Nguyen PL, Danielson B, Sandler HM, Feng FY. The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018. p. S13–S14.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2018
Volume
102
Issue
3
Start / End Page
S13 / S14
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences